Cargando…
Rifampicin for COVID-19
Vaccinations for coronavirus disease-2019 (COVID-19) have begun more than a year before, yet without specific treatments available. Rifampicin, critically important for human medicine (World Health Organization’s list of essential medicines), may prove pharmacologically effective for treatment and c...
Autores principales: | Panayiotakopoulos, George D, Papadimitriou, Dimitrios T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966591/ https://www.ncbi.nlm.nih.gov/pubmed/35433334 http://dx.doi.org/10.5501/wjv.v11.i2.90 |
Ejemplares similares
-
COVID-19 mRNA Vaccine Effectiveness against Elderly Frail People
por: Kountouras, Jannis, et al.
Publicado: (2023) -
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
por: Trougakos, Ioannis P., et al.
Publicado: (2022) -
COVID-19 and the liver: What do we know so far?
por: Nasa, Prashant, et al.
Publicado: (2021) -
COVID-19 pandemic: Monitoring space-time data and learning from global experience
por: Symvoulakis, Emmanouil K., et al.
Publicado: (2020) -
COVID-19 and liver injury in individuals with obesity
por: Lempesis, Ioannis G, et al.
Publicado: (2023)